Has Response Pharmacauticals won the fight against antipsychotic weight gain? 29-Apr-2024 By Liza Laws Response Pharmaceuticals, Inc., has unveiled significant findings from its Phase 1b clinical trial of RDX-002, signaling a potential breakthrough in combatting antipsychotic-induced weight gain (AIWG).